TY - JOUR AU - Chen, Yuexuan AU - Klute, Susanne AU - Bansal, Anju AU - Sparrer, Konstantin Maria Johannes AU - Serra-Moreno, Ruth TI - HIV-1 Vpr is targeted for degradation by autophagy. JO - PLoS pathogens VL - 22 IS - 3 SN - 1553-7366 CY - Lawrence, Kan. PB - PLoS M1 - DZNE-2026-00266 SP - e1014020 PY - 2026 AB - Autophagy is part of the innate immune arsenal to fight viruses, including HIV-1. We previously reported that HIV-1 Gag is targeted for autophagy-mediated degradation. Here, we identify HIV-1 Vpr, an important virulence factor, as an autophagy target in HIV-1 NL4-3, a lab adapted molecular clone. Notably, Vpr proteins from a collection of transmitted/founder viruses (TFVs) were resistant to autophagy. Based on this observation, we identified residues at positions 37, 45, 77, 83-86, 93-94 in NL4-3 Vpr as responsible for its susceptibility to autophagy. Importantly, differences between NL4-3 and TFV Vpr proteins at these positions impact their interaction with the autophagy receptors NDP52, SQSTM1/p62 and TAX1BP1. By engineering NL4-3 molecular clones harboring either autophagy-sensitive or -resistant vpr, we found that in 2D and 3D in vitro systems virus spread was significantly reduced for the virus carrying autophagy-sensitive Vpr. In conclusion, our study identifies Vpr as a novel autophagy target and suggests that Vpr susceptibility to autophagy impacts HIV-1 spread. KW - Autophagy: physiology KW - Humans KW - vpr Gene Products, Human Immunodeficiency Virus: metabolism KW - vpr Gene Products, Human Immunodeficiency Virus: genetics KW - HIV-1: metabolism KW - HIV-1: genetics KW - HIV-1: pathogenicity KW - HIV Infections: metabolism KW - HIV Infections: virology KW - HIV Infections: immunology KW - HEK293 Cells KW - Proteolysis KW - vpr Gene Products, Human Immunodeficiency Virus (NLM Chemicals) KW - vpr protein, Human immunodeficiency virus 1 (NLM Chemicals) LB - PUB:(DE-HGF)16 C6 - pmid:41770818 C2 - pmc:PMC12970978 DO - DOI:10.1371/journal.ppat.1014020 UR - https://pub.dzne.de/record/285490 ER -